Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference46 articles.
1. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;C Davies;Lancet,2011
2. Fulvestrant in the treatment of advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials;A Valachis;Crit Rev Oncol Hematol,2010
3. A potent specific pure antiestrogen with clinical potential;AE Wakeling;Cancer Res,1991
4. Mechanisms of endocrine resistance in breast cancer;CK Osborne;Annu Rev Med,2011
5. T47D breast cancer cells switch from ER/HER to HER/c-Src signaling upon acquiring resistance to the antiestrogen fulvestrant;T Kirkegaard;Cancer Lett,2014
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy;PLOS ONE;2024-02-23
2. Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer;Cancer Research;2023-10-31
3. Comprehensive Transcriptomic and Proteomic Analyses Identify a Candidate Gene Set in Cross-Resistance for Endocrine Therapy in Breast Cancer;International Journal of Molecular Sciences;2022-09-11
4. Targeting the FAK-Src Complex in Desmoplastic Small Round Cell Tumors, Ewing Sarcoma, and Rhabdomyosarcoma;Sarcoma;2022-05-12
5. LYN kinase and estrogen receptor ERα: involvement in carcinogenesis and potential therapeutic target for tumors;Advances in Molecular Oncology;2021-11-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3